• Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

    Source: Nasdaq GlobeNewswire / 13 Jun 2022 08:00:01   America/New_York

    N/A
Share on,